Daligdigan, Camlon D.

HRN: 23-46-23  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/31/2023
CEFTRIAXONE 1G (VIAL)
07/31/2023
08/06/2023
IV
2g
OD
Community-acquired Pneumonia
Waiting Final Action 
08/08/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
08/08/2023
08/15/2023
IV
500 Mg
Q8h
Bowel Obstruction
Waiting Final Action 
08/08/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
08/08/2023
08/14/2023
IV
500 Mg
Q8
Bowel Obstruction
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: